Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study-Reference-Cited by-同舟云学术

Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study

Published:2003-07-23 Issue:3 Volume:122 Page:394-403
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Hedenus Michael,Adriansson Magnus,Miguel Jesus San,Kramer Mark H. H.,Schipperus Martin R.,Juvonen Eeva,Taylor Kerry,Belch Andrew,Altés Albert,Martinelli Giovanni,Watson David,Matcham James,Rossi Gregory,Littlewood Timothy J.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2003.04448.x/fullpdf

Reference39 articles.

1. Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer;Abels;Seminars in Oncology,1992

2. Recombinant human erythropoietin and the anemia of multiple myeloma;Barlogie;Stem Cells,1993

3. Reductions in anemia and fatigue are associated with improvements in productivity;Berndt;Blood,2002

4. Epoietin in the treatment of malignant disease: a comprehensive meta-analysis;Bohlius;Blood,2002

Cited by 279 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bloodless surgery in urologic oncology: A review of hematologic, anesthetic, and surgical considerations;Urologic Oncology: Seminars and Original Investigations;2023-04

2. Anemia and iron deficiency in cancer patients: the role of intravenous iron supplements (a literature review);Journal of Modern Oncology;2023-02-01

3. Disparities in erythropoiesis-stimulating agent use after changes in medicare reimbursement and implementation of a risk evaluation and mitigation strategy;Drugs & Therapy Perspectives;2022-12-06

4. The addition of oral iron improves chemotherapy‐induced anemia in patients receiving erythropoiesis‐stimulating agents;International Journal of Cancer;2022-06-24

5. Intravenous iron versus oral iron versus no iron with or without erythropoiesis- stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta-analysis;Cochrane Database of Systematic Reviews;2022-06-20